Resolving Hexose-Phosphates by LC-MS Leads to New Insights in PGM1-CDG Pathophysiology
Karen Driesen1,2,3, Sam De Craemer1,2, Eva Morava4
1Laboratory of Applied Mass Spectrometry, Department of Cellular and Molecular Medicine, KU Leuven, Leuven 3000, Belgium.
ACS Omega
|September 29, 2025
Summary
We developed two liquid chromatography-MS methods to identify and quantify human hexose-phosphates. These methods accurately measure hexose-phosphate profiles in cells, aiding research into metabolic disorders like congenital disorders of glycosylation (CDG).
Area of Science:
- Metabolomics
- Biochemistry
- Analytical Chemistry
Background:
- Hexose-phosphates are crucial in metabolic pathways like glycolysis and glycosylation.
- Understanding hexose-phosphate levels is vital for studying diseases such as congenital disorders of glycosylation (CDG).
- Differentiating structural isomer hexose-phosphates using mass spectrometry (MS) is challenging due to similar physicochemical properties.
Purpose of the Study:
- To develop and compare optimized liquid chromatography-MS methods for identifying human hexose-phosphates.
- To enable accurate quantification of hexose-phosphates for tracer metabolomics applications.
- To analyze hexose-phosphate profiles in the context of CDG and treatment responses.
Main Methods:
- Development and comparison of two optimized liquid chromatography-MS methods.
- Validation of methods for linearity (3-4 orders of magnitude) and limits of quantification (0.5-50 nM).
- Application of the methods to analyze hexose-phosphate profiles in phosphoglucomutase 1 (PGM1)-CDG fibroblasts treated with galactose.
Main Results:
- Successful identification and quantification of eight hexose-monophosphates and two hexose-bisphosphates.
- Methods demonstrated high linearity and sensitivity suitable for cellular concentrations.
- First report of hexose-phosphate profiles in CDG fibroblasts and their changes upon galactose treatment.
Conclusions:
- The developed LC-MS methods are effective for differentiating and quantifying human hexose-phosphates in tracer metabolomics.
- These methods provide valuable insights into the molecular basis of CDG and other metabolic disorders.
- The study demonstrates the utility of these methods in analyzing disease-specific metabolic alterations and treatment effects.
Related Concept Videos
Biosynthesis of Polysaccharides
557
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
557
Other Glycolytic Pathways
827
The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...
827
Glycolysis: Preparatory Phase
16.5K
In cellular metabolism (the complete breakdown of glucose to extract energy), glycolysis is the first step. Glycolysis takes place in the cytoplasm of both prokaryotic and eukaryotic cells. Glucose enters heterotrophic cells in two ways. One method is through secondary active transport, where the transport takes place against the glucose concentration gradient. The other mechanism uses a group of integral proteins called GLUT proteins, also known as glucose transporter proteins. These...
16.5K


